Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127973751 | 12797375 | 1 | I | 20160929 | 20160929 | 20160929 | EXP | US-ROCHE-1836946 | ROCHE | 0.00 | M | Y | 0.00000 | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127973751 | 12797375 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | FOR OFFICE ADMINISTRATION BY YOUR PHYSICIAN, LEFT EYE | D | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 127973751 | 12797375 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | TABLET | ||||||||
| 127973751 | 12797375 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 25 | UG | TABLET | ||||||||
| 127973751 | 12797375 | 4 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 10 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127973751 | 12797375 | 1 | Neovascular age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127973751 | 12797375 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127973751 | 12797375 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |